A recognized leader in radiation oncology, Dr. Kavadi brings extensive experience in patient care, research and operations to The Network
THE WOODLANDS, Texas, Aug. 4, 2020 — Vivek S. Kavadi, MD, FASTRO, a nationally known expert in the field of radiation oncology, has been named chief radiation oncology officer for The US Oncology Network (The Network). Dr. Kavadi will lead the development of clinical strategies and best practices to advance the delivery of cutting-edge radiation therapies across The Network, as well as spearhead new initiatives in radiation oncology that empower practices to thrive in the challenging value-based care environment.
“Dr. Kavadi is a nationally recognized expert in radiation oncology and a well-respected physician-leader within The Network,” said Michael Seiden, MD, PhD, president, The US Oncology Network. “He has extensive experience that spans patient care, research and operations and has an in-depth knowledge of The Network, having served as chairman of the radiation executive committee and medical director of radiation oncology. We are very excited Dr. Kavadi will now lead our efforts to advance radiation therapy and integrated care while continuing to drive the critical role The Network is playing in the transition to value-based care.”
Dr. Kavadi has been a practicing radiation oncologist for nearly 30 years, most recently treating patients at Texas Oncology. As a member of the Board of Directors of Texas Oncology―a practice in The Network with more than 200 sites of service―Dr. Kavadi has in-depth experience in building and managing high performing radiation oncology departments. Board certified in radiation oncology, he has a clinical interest in prostate and breast cancer and is Primary Investigator for The US Oncology Network RTOG Affiliation. Dr. Kavadi graduated from Rice University and received his medical degree from Harvard Medical School. He then completed a transitional internship at Baylor College of Medicine and a residency in radiation oncology at M.D. Anderson Cancer Center where he was chief resident. He is currently pursuing an MBA at the Wharton School.
“Dr. Kavadi is a highly regarded leader in radiation oncology, and we are honored he has chosen to join our team,” said Marcus Neubauer, MD, chief medical officer, The US Oncology Network. “He brings extraordinary leadership skills and clinical expertise in radiation oncology to our organization. I look forward to collaborating with him on initiatives to empower The Network practices to thrive in today’s evolving landscape.”
Dr. Kavadi has received many accolades throughout his career and was recently named a fellow by the American Society for Radiation Oncology (ASTRO), a recognition usually only awarded to radiation oncologists working in academic settings rather than private practice. He was recognized by ASTRO for his leadership, service, research, patient care and educational contributions to the organization, as well as the field of radiation oncology.
“Joining The Network in this capacity provides a wonderful opportunity to meet the goals I have always had throughout my career―to deliver high-quality cutting-edge care, to contribute to the advancement of my field and to provide meaningful leadership when the opportunity arose,” said Dr. Kavadi. “The US Oncology Network is a world-class organization with tremendous resources that is dedicated to enhancing cancer care across local communities, and I look forward to contributing to this worthwhile goal.”
About The US Oncology Network
Every day, The US Oncology Network (The Network) helps more than 1,350 independent physicians deliver value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network provides practices with access to coordinated resources, best business practices, and the experience, infrastructure and support of McKesson Corporation. This collaboration allows the providers in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. The Network is committed to the success of independent practices, everywhere.